New patent for Genus Lifesciences drug GOPRELTO

January 8, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for GOPRELTO Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. There are six patents protecting this drug. Drug patent litigation…

The post New patent for Genus Lifesciences drug GOPRELTO appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.